$KERX Recent News Six stocks to watch 1:47 p.m. Aug.

New Post Public Reply Private Reply Replies (0) Message Board

Sep 18, 2014 at 10:07 AM

$KERX Recent News

Six stocks to watch 1:47 p.m. Aug. 27, 2014 - The Trading Deck
When it rains, it pours for Nasdaq leadership 12:47 p.m. March 27, 2014 - The Trading Deck
Six stocks to watch 4:27 p.m. Feb. 26, 2014 - The Trading Deck
Nasdaq extends break to less-charted territory 12:42 p.m. Dec. 2, 2013 - Michael Ashbaugh
6 movers to watch 3:08 p.m. Nov. 6, 2013 - The Trading Deck
Keryx climbs after treatment shows positive result 11:01 a.m. Nov. 5, 2013 - MarketWatch.com
Six stocks to watch for some upside 3:21 p.m. April 11, 2013 - The Trading Deck
6 gut checks before the stock market's opening bell 7:47 a.m. March 7, 2013 - Shawn Langlois
Towerstream, Vanguard and others price offerings 11:32 a.m. Jan. 31, 2013 - MarketWatch.com
6 gut checks before the stock market's opening bell 7:52 a.m. Jan. 31, 2013 - Shawn Langlois
Keryx Biopharmaceuticals up 8.5% in premarket 8:58 a.m. Jan. 29, 2013 - Steve Gelsi
Monday’s movers: Herbalife clobbered on FTC news 5:30 p.m. Jan. 28, 2013 - Sue Chang
In focus: No letup by the bulls 8:45 p.m. Jan. 23, 2013 - Lawrence G. McMillan
Keryx Biopharma rises 17% in premarket trades 8:36 a.m. Jan. 23, 2013 - Steve Gelsi
Monday’s biggest gaining and declining stocks 4:37 p.m. April 23, 2012 - MarketWatch
Monday’s biggest gaining & declining stocks 5:56 p.m. April 2, 2012 - Kate Gibson
Keryx, AEterna implode on failed drug study 11:13 a.m. April 2, 2012 - Val Brickates Kennedy
Keryx, AEterna rally ahead of study results 1:34 p.m. March 16, 2012 - Val Brickates Kennedy
Keryx , AEterna rally ahead of study results 1:32 p.m. March 16, 2012 - Val Brickates Kennedy
Top longs and shorts to watch 1:18 p.m. March 6, 2012 - The Trading Deck

SEC Slaps Biotech Hedge Fund for Short-Selling Violations 1:04 p.m. Sept. 16, 2014 - TheStreet.com
If Achillion's Hep C Nucleotide Isn't Best In Class, The Stock Is Worth Low Single Digits 8:00 a.m. Sept. 16, 2014 - Seeking Alpha
Hottest Healthcare Stocks Now – ISIS PBYI KERX HALO 1:30 p.m. Sept. 11, 2014 - InvestorPlace.com
Insider Trading Alert - DVA, DATA And KERX Traded By Insiders 10:30 a.m. Sept. 11, 2014 - TheStreet.com
Biotech Stock Roundup: AbbVie Ties Up with Infinity, Keryx Slips on FDA Approval - Analyst Blog 11:17 a.m. Sept. 10, 2014 - Zacks.com
Keryx Biopharmaceuticals (KERX) Weak On High Volume Today 10:02 a.m. Sept. 10, 2014 - TheStreet.com
Keryx Biopharmaceuticals (KERX) Is Today's Roof Leaker Stock 1:34 p.m. Sept. 9, 2014 - TheStreet.com
Keryx's FDA Approval a Mixed Bag 7:47 a.m. Sept. 9, 2014 - Barrons.com
Deutsche Bank’s 4 Top Biotech Stocks to Buy for This Year and 2015 7:44 a.m. Sept. 9, 2014 - 247WallSt.com
Keryx Falls after Ferric Citrate's Approval with Warnings - Analyst Blog 6:05 p.m. Sept. 8, 2014 - Zacks.com
Silver Spring Networks Starts The Week Strong 1:30 p.m. Sept. 8, 2014 - TheStreet.com
Keryx Biopharmaceuticals' (KERX) CEO Ron Bentsur Discusses the approval of Ferric Citrate (Transcript) 1:18 p.m. Sept. 8, 2014 - Seeking Alpha
Keryx Biopharmaceuticals' (KERX) CEO Ron Bentsur Discusses FDA approval of Ferric Citrate (Transcript) 1:18 p.m. Sept. 8, 2014 - Seeking Alpha
Why Keryx Biopharmaceuticals (KERX) Stock Is Falling Today 11:25 a.m. Sept. 8, 2014 - TheStreet.com
Keryx Falls Victim To A Self-Fulfilling Prophecy, Creates Opportunity 10:05 a.m. Sept. 8, 2014 - Seeking Alpha
Keryx Biopharmaceuticals (KERX) Crumbles: Stock Falls by 5.5% - Tale of the Tape 8:55 a.m. Sept. 8, 2014 - Zacks.com
Analysts' Actions: AIG, Bank of America, Ford, FireEye and More 8:27 a.m. Sept. 8, 2014 - TheStreet.com
Top Analyst Upgrades and Downgrades: Altria, BofA, FireEye, Ford, J.P. Morgan, Linn Energy and More 7:51 a.m. Sept. 8, 2014 - 247WallSt.com
Keryx Bear Case Bolstered by Less-Than-Zippy 'Zerenex' Label 7:00 a.m. Sept. 8, 2014 - TheStreet.com
Keryx Finds Out That Not All FDA Approvals Are Wins 2:17 p.m. Sept. 5, 2014 - 247WallSt.com

Market Activity, Drug Approval, Upcoming Conference, and Presentation of Clinical Data - Research Reports on Jazz, Keryx, Vertex, WellPoint and GSK 9:15 a.m. Sept. 10, 2014 - PR Newswire - PRF
Biotech Stocks Under Review -- Keryx Biopharma, Sangamo BioSciences, Regeneron Pharma, Sunesis Pharma, and Idera Pharma 9:10 a.m. Sept. 9, 2014 - PR Newswire - PRF
Keryx Biopharmaceuticals, Inc. to Present at the Rodman & Renshaw 16th Annual Global Investment Conference 4:01 p.m. Sept. 5, 2014 - GlobeNewswire
Keryx Biopharmaceuticals Receives FDA Approval of Ferric Citrate, a New, Oral Iron-Based Treatment for Dialysis Patients With Hyperphosphatemia 11:41 a.m. Sept. 5, 2014 - Thomson Reuters ONE
Keryx Biopharmaceuticals Receives FDA Approval of Ferric Citrate, a New, Oral Iron-Based Treatment for Dialysis Patients With Hyperphosphatemia 11:19 a.m. Sept. 5, 2014 - GlobeNewswire
Keryx Biopharmaceuticals, Inc. Announces Second Quarter and Six Month 2014 Financial Results 7:02 a.m. Aug. 7, 2014 - GlobeNewswire
Biotech Equities Roundup -- Keryx Biopharma, Vertex Pharma, NPS Pharma, Cubist Pharma, and Idera Pharma 8:50 a.m. Aug. 6, 2014 - PR Newswire - PRF
Keryx Biopharmaceuticals, Inc. to Host Conference Call on Second Quarter 2014 Financial Results 8:02 a.m. Aug. 5, 2014 - GlobeNewswire
Conference Call Schedules, Publication of Study Results, and Public Offer Pricing - Research Reports on Medivation, Keryx, Amicus, AGTC and Clovis 8:50 a.m. July 30, 2014 - PR Newswire - PRF
Zerenex(TM) (Ferric Citrate) Long-Term Phase 3 Study Results Published in the Journal of the American Society of Nephrology 5:01 p.m. July 24, 2014 - GlobeNewswire
Zerenex(TM) (Ferric Citrate) Long-Term Phase 3 Study Results Published in the Journal of the American Society of Nephrology 5:00 p.m. July 24, 2014 - Thomson Reuters ONE
Leadership Appointments, Earnings Conference Calls, Milestone Payments, and Technical Updates - Analyst Notes on Illumina, Alexion, Incyte, Clovis and Keryx 8:10 a.m. July 17, 2014 - PR Newswire - PRF
Patent Issuance, Positive Trial Data, Recognitions, and Priority Review - Analyst Notes on Keryx, Puma, Ligand, Sagent and Enanta 7:50 a.m. June 30, 2014 - PR Newswire - PRF
Health Care Sector Equities Technical Coverage -- Research on Keryx Biopharma, Thoratec, Unilife, and VIVUS 7:10 a.m. June 30, 2014 - PR Newswire - PRF
Keryx Biopharmaceuticals Announces Issuance of Two U.S. Patents for Zerenex(TM) Covering Orally Administrable Forms of Ferric Citrate 8:31 a.m. June 18, 2014 - GlobeNewswire
Keryx Biopharmaceuticals Announces Issuance of Two U.S. Patents for Zerenex(TM) Covering Orally Administrable Forms of Ferric Citrate 8:31 a.m. June 18, 2014 - Thomson Reuters ONE
Keryx Biopharmaceuticals, Inc. to Present at the 9th Annual JMP Securities Healthcare Conference 4:30 p.m. June 17, 2014 - GlobeNewswire
Trial Results, Patient Enrollment, and Strategic Collaborations - Analyst Notes on Alnylam, Celldex, Keryx, Spectrum and MacroGenics 5:20 a.m. June 12, 2014 - PR Newswire - PRF
Keryx Biopharmaceuticals, Inc. to Present at the 35th Annual Goldman Sachs Global Healthcare Conference 8:34 a.m. June 5, 2014 - GlobeNewswire
Pre-Market Review on Biotechnology Equities -- Research on BioMarin Pharma, Keryx Biopharma, Amgen, and Peregrine Pharma 8:30 a.m. May 30, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

BETR's Legal Clash: Investor Action Deadline Nears

BETR's Woes in the Legal Spotlight Investors who’ve been keeping an eye on Better Home & Finance Holding Company—trading as BETR on NASDAQ—might wanna pinch themselves. Not every day do you see a class action lawsuit waiting on the horizon like this one. The folks over at Schall, Brown & Schwartz LLP, those wily veterans in shareholder rights litigation, are...

Alaska LNG Project Boosted by Strategic Positioning

Alaska LNG: Right Place, Right Time Someone bring out the confetti, because Paul Sullivan, Co-Chairman of Gastech, is celebrating Alaska LNG like it's 1999. And for good reason. If Alaska ever played its cards right, now's the moment according to the industry veteran. After Gastech 2026 wrapped its events in Bangkok last month, Sullivan laid out why the stars are aligning...

Community Heritage Financial Declares Q3 2026 Dividend

Dividend Declared Amidst Challenging Times There's nothing quite like the ringing of a cash register, and for Community Heritage Financial, Inc. (OTCID: CMHF), that's what an $0.08 per share dividend feels like. Declared for the third quarter of 2026, this payout is set to line the pockets of shareholders who made the cut by October 30, 2026. The folks waiting for their...

Chicago Scenic Studios’ Equipment Up for Grabs in Auction

A Peek into the Sale: What's on the Block? Get that coffee brewing and settle in, because we've got to unpack some interesting stuff happening with Chicago Scenic Studios. This isn't just any Craigslist decampment—Integra Asset Solutions is rolling out an online auction come October 27 that’ll have equipment-savvy investors’ ears perking up like they just snagged a...

ASTS Fraud Lawsuit: Investors' Chance to Step Up

Investors Grapple with AST SpaceMobile's Legal Challenges When I hear 'securities fraud lawsuit,' my gut instinct as a trader is to dig deep into the grime and figure out what's lurking beneath. AST SpaceMobile, those folks aiming to shake up the satellite game, have some explaining to do. If you've been holding onto ASTS shares between March 4, 2025, and July 15, 2026,...

Cruise Planners Sets AI Benchmark in Travel Innovs

Unveiling the AI Arsenal of Cruise Planners Alright, listen up, folks. When you think about travel and tech, Cruise Planners ain't just dipping a toe—they're cannonballing right in, splashing everyone around with their shiny new AI tricks. Twenty-three. That's how many innovations they're flaunting this year. It's like they're running a tech marathon, and boy, are they...

Revolutionizing Talent Matching with Match2's Latest Upgrades In the churn of today's recruiting jungle, candidates and employers have been grappling with disjointed systems and outdated approaches. Well, Match2 is cutting through that noise with some hefty upgrades. It's got some new toys in the shed—specifically, a beefed-up Universal Candidate Profile™ and an...

Dickinson Brands Celebrates Witch Hazel Legacy with Event

Witch Hazel's Timeless Appeal You don’t get to celebrate over one and a half centuries of a product without doing something right. Dickinson Brands Inc. is throwing a bash worth noticing as they mark the sixth annual National Witch Hazel Day on October 21st. It’s a head-nod to the versatile witch hazel, a product that’s been part of New England's heritage since the...

Art Print Paper: Finding the Perfect Match for Masterpieces

You ever stand in a gallery and notice how some art just lights up the room while others barely get a second glance? Well, a lot of that magic starts with an unsung hero—paper choice. I came across this bit from HelloNation diving into what makes paper selection a cornerstone for fine art prints. Now, I ain't an artist, but even a bruiser trader like me can see the...

Spire's Year-End Call: Eyes on Earnings & Guidance

Anticipation Builds for Spire's Upcoming Earnings Call If you're keen on natural gas and the energy sector, keep a firm grip on your coffee cup because Spire Inc. (NYSE: SR) is about to spill the beans on their fiscal 2026 financials. Mark your calendars for November 17. Whether you're tuning in via phone or hitching a ride on the webcast, you're in for an earful. Time...